FDA Says Up to Two Million People Exposed to Likely Carcinogens in Blood-Pressure Drugs

As many as two million people world-wide have been exposed to a class of generic blood-pressure drugs containing probable human carcinogens from raw-material facilities in China and India, according to U.S. officials.

Half or more of the patients taking the common hypertension medicines are in the U.S., the Food and Drug Administration officials said. The drugs are certain lots of some manufacturers’ products, including generic drugs going by the names valsartan, irbesartan and losartan.

Click here to view full article.